GlaxoSmithKline PLC’s Consumer Healthcare business could ease the pain of slumping sales for Excedrin Migraine with a campaign using "augmented reality" technology to open a window to the day-to-day struggles of migraine sufferers.
“The Migraine Experience” campaign could provide a much-needed bump for the brand's sales, which fell 11.4% from the year-ago period to $70
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?